SEC Info - Mimedx Group, Inc. - ‘8-K’ for 10/10/16

SEC Info℠

Home

Help

Please Sign In

Mimedx Group, Inc. – ‘8-K’ for 10/10/16

On: Wednesday, 10/12/16, at 4:05pm ET · For: 10/10/16 · Accession #: 1376339-16-207 · File #: 1-35887

  As Of                Filer                Filing    For·On·As Docs:Size

10/12/16  Mimedx Group, Inc.                8-K:2,9    10/10/16    2:42K

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     16K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     14K

8-K — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934

Date of Report (date of earliest event reported): October 10, 2016

MIMEDX GROUP, INC.

(Exact name of registrant as specified in charter)



Florida (State or other jurisdiction of incorporation)	001-35887 (Commission File Number)	26-2792552 (IRS Employer Identification No.)



1775 West Oak Commons Ct, NE Marietta, GA (Address of principal executive offices)		30062 (Zip Code)

(770) 651-9100

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:



o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)



o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)



o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))



o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Item 2.02	Results of Operations and Financial Condition

On October 10, 2016, MiMedx Group, Inc. (the “Company”) issued a press release announcing certain financial results for the third quarter of 2016. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information provided pursuant to Item 2.02 of this Form 8-K is to be considered “furnished” and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.



Item 9.01	Financial Statements and Exhibits


(c)	Exhibits



Exhibit No.		Description

99.1		MiMedx Group, Inc. Press Release, dated October 10, 2016

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



Dated:	October 12, 2016	MIMEDX GROUP, INC.


		By:	/s/: Michael J. Senken
			Michael J. Senken, Chief Financial Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on:	10/12/16	None on these Dates
For Period End:	10/10/16
		List all Filings

↑Top

Filing Submission 0001376339-16-000207 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)